Dump These 3 High-Yield Turkeys Now

Turkey is the traditional Thanksgiving fare, and I don’t know anyone who doesn’t like to sit down to a full-spread Turkey dinner on the holiday (OK, my sister the vegetarian is an exception. She just wants her dinner to taste like turkey). However, what we don’t want are turkeys in our stock portfolio. In the case of high yield stocks, those are ones where the dividend payment is at risk of disappearing like the pie on Thanksgiving.

The results from high-yield stock investments tend to have a binary outcome. The reason for the high yield on an individual stock is because there is a market perception that the dividend rate is at risk. You have likely heard the saying that high-yield equals high risk.

The outcome for an individual dividend stock will go one of two ways. One possible outcome is that the market is right and the dividend is reduced or eliminated. When this happens, it’s bad news in a stock portfolio. Dividend cuts also come with steep share price declines. The other potential outcome is that the market is wrong, and the company continues to pay the current dividend or even grow the payout rate.

My research for my Dividend Hunter high-yield stock focused service is focused on finding the second kind of big dividend paying stock.

Today I want to highlight a few stocks in the first group. Many investors pick income stocks just from the yield and don’t analyze the underlying financials to see if a company is positioned to sustain the dividends.

The analysis steps are different in the high-yield world, and if you have not been exposed to the techniques, you will likely end up cursing the idea of investing for yield.

Here are three, that if you own them, my suggestion is to sell before the dividend gets cut any you are left with a lot less income and value in your brokerage account.

Martin Midstream Partners L.P. (Nasdaq: MMLP) is a high-yield master limited partnership. The shares currently yield over 17%. After a decade of dividend growth, the music stopped and in November 2016 the company slashed its payout by 38%.

You might assume or hope that after the big reduction the management team would have put itself into a position to support the new lower dividend rate and at some point, resume growth.

It appears that is not the case. For the first three quarters of 2018, the company generated distributable cash flow coverage of just 76% of the distributions paid to investors.

The company says it will soon be able to cover the distributions with cash flow, but too many times have I seen businesses like this be forced into a dividend cut before the cash flow gets high enough to sustain the current dividend rate.

AGNC Investment Corp (Nasdaq: AGNC) is the largest of a group of finance real estate investment trusts (REITs) that own portfolios of government agency backed mortgage backed securities, often called MBS. You will see these referred to as Freddie Mac, Fannie Mae and Ginnie May mortgage backed bonds.

The challenge for AGNC and all the agency MBS owning finance REITs is taking the 4% yield of these bonds up to a double digit stock yield. The step up in yield is done with large amounts of leverage. An agency REIT will leverage its equity 5 to 10 times with borrowed money.

For the 2018 third quarter AGNC reported leverage of 8.5 times book value. The problem with this amount of leverage is that a flattening of the yield curve can wipe out the net interest margin and the ability to continue paying dividends.

History has shown that these REITs are better for management compensation than they are for investors looking for stable dividend payments. The AGNC dividend has shrunk by 14% per year on average over the last five years.

Ignore the 12% yield and sell.

CBL & Associates Properties, Inc. (NYSE: CBL) is a shopping mall REIT on the wrong side of the shopping center great divide. At one end are the successful REITs that own Class A malls which are 95% plus occupied with successful retailers. At the other end are the REITs that own malls with fading demographics anchored by declining retailers like Sears and JC Penny.

These second tier malls will require millions in capital spending to make them again attractive to shoppers, and that spending may not do the trick. Shoppers are fickle, and it may be impossible to draw them back to a near failed mall.

It’s easy to tell the difference between the successful mall REITs and the trouble ones. The good REITs in the shopping center category have yields under 5%. The challenged ones have double digit yields. In the case of mall REITs, the high yield is a true danger signal to sell and stay away.

CBL yields 10.7%.

Get up to 14 dividend paychecks per month from safe, reliable stocks with The Monthly Dividend Paycheck Calendar, an easy-to-use system that shows you which dividend stocks to pick, when to buy them, when you get paid your dividends, and how much.  All you have to do is buy the stocks you like and tell them where to send your dividend payments. For more information Click Here.

Buy This Marijuana Stock to Tap Into Legal Pot’s Next Growth Phase

Now that the bloom is off the cryptocurrency rose, investors looking for the latest hot sector have descended upon the pot stock space. Marijuana-related companies look likely to have raised $8 billion from investors in 2018.

And that’s understandable – estimates are that it could be a $150 billion sector within a decade. The growth in the marijuana sector has been greatly aided by recent developments – the legalization of pot by Canada in mid-October and the Democrats winning control of the U.S. House of Representatives. The latter makes it more likely the U.S. will legalize cannabis nationally. Already, a number of states have legalized marijuana, with Michigan being the latest.

From just a $5 billion market in 2015, the legal cannabis industry in North America is expected, in the most conservative estimates, to top $20 billion by 2020. North America is pretty much the global legal pot market at the moment since about 90% of global legal revenues currently come from the U.S. and Canada.

Here though is the most exciting part of the growth story of the legal pot market…

Marijuana-Infused Drinks Coming

Cannabis sales are only a small fraction of alcohol sales, but that is likely to change when major beverage companies enter the market and start replacing alcohol content with cannabis content.

And there is a similar story that looks to be unfolding in the non-alcoholic beverage market also. That growth story is why some of the world’s leading beverage companies have shown interest in the sector.

Some drinks companies are seriously looking at adding CBD (cannabidiol) – the non-psychoactive part of marijuana – into drinks aimed at the mass market. These drinks containing cannabidiol and focused on pain management could become big business. Analysts at Cannacord Genuity estimate that sales of drinks infused with CBD could make up 20% of the edibles market and will reach $600 million in sales in the U.S. by 2022.

Or as a recent Bloomberg article put it, pot has “moved from the black market to the stock market and now appears to be on its way to the supermarket.”

Coca-Cola (NYSE: KO) said it is looking at the possibility of infusing CBD into “functional wellness beverages around the world.” Coke is no doubt looking to broaden the reach of cannabis-infused beverages into functional wellness categories, enabling the company to potentially one day be a major player in the non-recreational cannabis-infused beverage category.

Other drinks companies in the alcoholic beverages space have or are contemplating jumping into the pot sector.

In August, Molson Coors Brewing (NYSE: TAP) jumped in by starting a joint venture with Hexo Corp (OTC: HYYWF)to develop non-alcoholic, cannabis-infused beverages for the Canadian market.

And Diageo (NYSE: DE), the drinks conglomerate behind Johnny Walker whiskey and Guinness beer, has also been exploring investment opportunities in the cannabis sector in recent months. It is thought that Diageo, the world’s biggest alcohol company, has had serious discussions with at least three major Canadian marijuana companies.

The maker of Corona beer and Modelo Especial, Constellation Brands (NYSE: STZ) has taken a giant leap into the sector when it invested just under $4 billion into the Canadian cannabis group Canopy Growth (NYSE: CGC), lifting its stake to 38%. Underlining the company’s bullish projections for cannabis, Constellation CEO Rob Sands acknowledged that the industry could represent “one of the most significant global growth opportunities for the next decade”.

Tread Carefully

However, you must still tread carefully when it comes to investing in the cannabis sector. After all, these companies are still money losers.

Let’s look at three of North America’s largest cannabis companies – Tilray (Nasdaq: TLRY)Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC).

In their latest earnings reports, revenues soared by 85%, 260%, and 33% respectively. But Tilray had a net loss of $18.7 million; Aurora had an operating loss of $112 million; and Canopy Growth had a net loss of $330.6 million.

In other words, these companies have costs that are rising faster than revenue. While some marijuana companies are starting to see the size of their losses slow, not one is profitable, and it could still take some time before they start making money.

Another worrisome item is the fact that the cost-per-gram is falling in Ontario (Canada’s most populous province) as the provincial government is buying product in bulk and at their set prices. (Canada’s cannabis companies can’t sell directly to retailers.) Tilray’s average per-gram price fell to $6.21 from $7.53.

It will still be months too before Canada’s pot companies produce enough to meet the strong demand. Until then, they’ll be spending big money on developing larger greenhouses. For instance, in August, Aurora announced it was starting production on a 1.2 million-square-foot facility, which will take months to build.

Cannabis Investments

These problems are why I do not like a broad play on the industry such as you would get through the ETFMG Alternative Harvest ETF (NYSE: MJ). Instead, I prefer to look for individual opportunities.

One company that is definitely on my list is CannTrust Holdings (OTC: CNTTF), which will be listing soon on the NYSE. It is in active discussions with a number of firms in the beverage, food and cosmetics industries and expects to announce a deal within the next two months.

This strategy is in contrast to that of Canopy Growth, which is tying itself to Constellation Brands. The chairman of CannTrust, Eric Paul, told Bloomberg “Ideally, it would be great to have a bunch of brand partners. We’d like to find the best partner for every one of those verticals [beverages, food, etc.]”

I was impressed too with its third results. Here are some of the highlights:

  • Record revenues of $12.6 million, a 105% increase from the comparable prior year period
  • Operations for the quarter resulted in positive EBITDA and positive net income
  • Active patients increased to more than 50,000, a 61% increase from the comparable prior year period
  • Entered into supply agreements with 9 Canadian provinces to supply recreational cannabis across Canada
  • Made its first shipment of cannabis oil to Denmark – the only cannabis oil accepted in Denmark
  • Partnered with Australia’s Gold Coast University Hospital on a six-month study designed to evaluate the efficacy of CannTrust CBD capsules in slowing the progression of Amyotrophic Lateral Sclerosis (ALS) progression
  • Partnered with McMaster University on medicinal cannabis research for chronic pain and for designing more effective, safer treatment protocols in public health policies

And despite a 20% move up after the earnings announcement, CannTrust stock sells at a much cheaper valuation than its peers.

There is also another cannabis-related company I like a lot that I have recommended to my Growth Stock Confidential subscribers. It is a more conservative way to approach the sector through a REIT that pays regular dividends.

Stay tuned for more on the sector in upcoming articles and special reports.

Buffett just went all-in on THIS new asset. Will you?
Buffett could see this new asset run 2,524% in 2018. And he's not the only one... Mark Cuban says "it's the most exciting thing I've ever seen." Mark Zuckerberg threw down $19 billion to get a piece... Bill Gates wagered $26 billion trying to control it...
What is it?
It's not gold, crypto or any mainstream investment. But these mega-billionaires have bet the farm it's about to be the most valuable asset on Earth. Wall Street and the financial media have no clue what's about to happen...And if you act fast, you could earn as much as 2,524% before the year is up.
Click here to find out what it is.